Nanomedicine delivery systems remodel the immunosuppressive microenvironment of colorectal cancer: synergistic strategies and mechanisms of targeted immune checkpoint inhibitors - Takeaways - MDSpire

Nanomedicine delivery systems remodel the immunosuppressive microenvironment of colorectal cancer: synergistic strategies and mechanisms of targeted immune checkpoint inhibitors

  • By

  • Pengcheng Zhu

  • Anna Han

  • Chunhua Quan

  • June 26, 2026

  • 0 min

Share

  • 1

    Colorectal cancer (CRC) has a five-year survival rate of less than 15% in advanced stages, highlighting the need for innovative treatment strategies.

  • 2

    Targeted immunotherapy, including immune checkpoint inhibitors, faces challenges due to the immunosuppressive tumor microenvironment in CRC.

  • 3

    Nanomedicine can enhance drug delivery and immunomodulation, potentially overcoming barriers to effective CRC treatment.

  • 4

    Immunosuppressive cells like Tregs, MDSCs, and TAMs create a network that hinders anti-tumor immune responses in CRC.

  • 5

    Nanodrug delivery systems can target and reprogram immunosuppressive cells, improving the efficacy of immunotherapy in CRC.

Original Source(s)

Nanomedicine delivery systems remodel the immunosuppressive microenvironment of colorectal cancer: synergistic strategies and mechanisms of targeted immune checkpoint inhibitors

  • by Pengcheng Zhu, Anna Han, Chunhua Quan

  • June 26, 2026

Related Content

Physical Activity Interventions Using Digital Health Interventions for Cancer-Related Fatigue in People With a History of Cancer: Scoping Review

MRI biomarkers of primary CNS lymphoma outcome after MATRix: real world performance

A spatiotemporal state-inference framework for adaptive immunotherapy in glioblastoma